NeuRizer Past Earnings Performance
Past criteria checks 0/6
NeuRizer's earnings have been declining at an average annual rate of -16.8%, while the Chemicals industry saw earnings growing at 9.8% annually.
Key information
-16.8%
Earnings growth rate
1.8%
EPS growth rate
| Chemicals Industry Growth | 14.4% |
| Revenue growth rate | n/a |
| Return on equity | -10.3% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How NeuRizer makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -8 | 4 | 0 |
| 30 Sep 23 | 0 | -12 | 7 | 0 |
| 30 Jun 23 | 0 | -16 | 10 | 0 |
| 31 Mar 23 | 0 | -19 | 10 | 0 |
| 31 Dec 22 | 0 | -22 | 10 | 0 |
| 30 Sep 22 | 0 | -21 | 9 | 0 |
| 30 Jun 22 | 0 | -20 | 8 | 0 |
| 31 Mar 22 | 0 | -19 | 9 | 0 |
| 31 Dec 21 | 0 | -18 | 9 | 0 |
| 30 Sep 21 | 0 | -16 | 8 | 0 |
| 30 Jun 21 | 0 | -14 | 7 | 0 |
| 31 Mar 21 | 0 | -11 | 6 | 0 |
| 31 Dec 20 | 0 | -8 | 5 | 0 |
| 30 Sep 20 | 0 | -8 | 5 | 0 |
| 30 Jun 20 | 0 | -7 | 4 | 0 |
| 31 Mar 20 | 0 | -8 | 4 | 0 |
| 31 Dec 19 | 0 | -8 | 4 | 0 |
| 30 Sep 19 | 0 | -9 | 4 | 0 |
| 30 Jun 19 | 0 | -10 | 5 | 0 |
| 31 Mar 19 | 0 | -9 | 5 | 0 |
| 31 Dec 18 | 0 | -8 | 5 | 0 |
| 30 Sep 18 | 0 | -7 | 4 | 0 |
| 30 Jun 18 | 0 | -6 | 4 | 0 |
| 31 Mar 18 | 0 | -6 | 3 | 0 |
| 31 Dec 17 | 0 | -5 | 3 | 0 |
| 30 Sep 17 | 0 | -6 | 4 | 0 |
| 30 Jun 17 | 0 | -6 | 4 | 0 |
| 31 Mar 17 | 0 | -6 | 3 | 0 |
| 31 Dec 16 | 0 | -6 | 3 | 0 |
| 30 Sep 16 | 0 | -6 | 3 | 0 |
| 30 Jun 16 | 0 | -5 | 3 | 0 |
| 31 Mar 16 | 0 | -12 | 3 | 0 |
| 31 Dec 15 | 0 | -19 | 3 | 0 |
| 30 Sep 15 | 0 | -19 | 2 | 0 |
| 30 Jun 15 | 0 | -18 | 1 | 0 |
| 30 Jun 14 | 0 | 0 | 0 | 0 |
Quality Earnings: NRZ is currently unprofitable.
Growing Profit Margin: NRZ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NRZ is unprofitable, and losses have increased over the past 5 years at a rate of 16.8% per year.
Accelerating Growth: Unable to compare NRZ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NRZ is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (4.9%).
Return on Equity
High ROE: NRZ has a negative Return on Equity (-10.26%), as it is currently unprofitable.